Expression of Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF does not result in eye defects.
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has visible phenotype, enhanceable by Bre1[+]/Bre1kim1
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has visible phenotype, enhanceable by Bre1GD5127, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has visible phenotype, enhanceable by EcRV559fs
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has visible phenotype, suppressible | partially by EcRA483T
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has visible phenotype
Scer\GAL4GMR.PF, Usp7UAS.cKa, burC95A.UAS has visible phenotype
Scer\GAL4GMR.PF, Usp7UAS.cKa, burS242L.UAS has visible phenotype
Bre1[+]/Bre1kim1, Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has partially lethal - majority die phenotype
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has eye phenotype, enhanceable by Bre1[+]/Bre1kim1
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has eye phenotype, enhanceable by Bre1GD5127, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has eye phenotype, enhanceable by EcRV559fs
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has eye phenotype, suppressible | partially by EcRA483T
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has eye phenotype
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has ommatidium phenotype
Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa has interommatidial bristle phenotype
Scer\GAL4GMR.PF, Usp7UAS.cKa, burC95A.UAS has eye phenotype
Scer\GAL4GMR.PF, Usp7UAS.cKa, burS242L.UAS has eye phenotype
Simultaneous co-expression of burScer\UAS.cLa and Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF results in defects in the eye characterised by disorganized or missing ommatidia, loss of bristles and black necrotic patches.
Simultaneous co-expression of burC95A.Scer\UAS and Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF results in defects in the eye similar to those caused by co-expression of burScer\UAS.cLa and Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF.
Simultaneous co-expression of burS242L.Scer\UAS and Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF results in defects in the eye similar to those caused by co-expression of burScer\UAS.cLa and Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF.
Animals expressing burScer\UAS.cLa and Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF and also heterozygous for Bre1kim1 show strongly reduced viability. Surviving adults have a strongly enhanced mutant eye phenotype compared to animals expressing burScer\UAS.cLa and Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF in an otherwise wild-type background.
Animals expressing Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF in a Bre1kim1/+ background do not show eye defects.
Co-expression of Bre1GD5127 enhances the eye defects caused by co-expression of burScer\UAS.cLa and Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF.
EcRV559fs enhances the eye defects caused by co-expression of burScer\UAS.cLa and Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF.
EcRA483T partially suppresses the eye defects caused by co-expression of burScer\UAS.cLa and Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF.